You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博瑞醫藥(688166.SH)獲注射用醋酸卡泊芬淨藥品註冊批件
格隆匯 01-13 19:00

格隆匯1月13日丨博瑞醫藥(688166.SH)公佈,近日,公司子公司信泰製藥(蘇州)有限公司收到國家藥品監督管理局核准簽發的“注射用醋酸卡泊芬淨”《藥品註冊批件》。

注射用醋酸卡泊芬淨的適應症為:適用於成人患者和兒童患者(三個月及三個月以上):1、經驗性治療中性粒細胞減少、伴發熱患者的可疑真菌感染;2、治療念珠菌血症和以下念珠菌感染:腹腔膿腫、腹膜炎和胸膜腔感染。尚未研究本品在由念珠菌感染引起的心內膜炎、骨髓炎和腦膜炎中的作用;3、治療食道念珠菌病;4、治療對其他治療無效或者不能耐受(例如:兩性黴素B、兩性黴素B脂質體、伊曲康唑)患者的侵襲性麴黴菌病。尚未研究本品作為侵襲性麴黴菌病的初始治療的作用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account